Country (Number of Respondents) | Total Patients (n = 216)* | Clinically Inactive Disease†| Remission‡ | Calcinosis | Interstitial Lung Disease | Deaths |
---|---|---|---|---|---|---|
Northern Africa (12; 60%) | Â | Â | Â | Â | Â | Â |
 Egypt (6] | 68* | 28 | 13 | 36 | 5 | 2 |
 Libya [3] | 55* | 18+ | 39+ | 12 | 5+ | 3 |
 Morocco [1] | 19 | 6 (31.6%) | 4 (21.1%) | 7 (36.8%) | 6 (31.6%) | 0 (0%) |
 Tunisia [2] | 3* | 6 | 6 | 0 | 4 | 0+ |
Eastern Africa (3; 15%) | Â | Â | Â | Â | Â | Â |
 Kenya [2] | 42 | 15 (35.7%) | 12 (28.6%) | 13 (31.0%) | 8 (19.0%) | 6 (14.3%) |
 Zambia [1] | 7 | 5 (71.4%) | 0 (0%) | 3 (42.9%) | 1 (14.3%) | 2 (28.6%) |
Central Africa (3; 15%) | Â | Â | Â | Â | Â | Â |
 Cameroon [2]** | 11 | 6 (54.5%) | 5 (45.5%) | 3 (27.3%) | 2 (18.2%) | 0 (0%) |
 Democratic Republic of the Congo [1]** | 3 | 3 (100%) | 1 (33.3%) | 3 (100%) | 0 (0%) | + |
Western Africa (1; 5%) | Â | Â | Â | Â | Â | Â |
 Nigeria [1] | 4 | 2 (50.0%) | 1 (25.0%) | 0 (0%) | 1 (25.0%) | 0 (0%) |
Southern Africa (1; 5%) | Â | Â | Â | Â | Â | Â |
 South Africa [1] | 4 | 1 (25.0%) | 1 (25.0%) | 2 (50.0%) | 0 (0%) | 0 (0%) |